We are live on ! Find out more
KALA icon

KALA BIO

13 hedge funds and large institutions have $4.81M invested in KALA BIO in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

6.38% less ownership

Funds ownership: 22.12% → 15.74% (-6.4%)

19% less funds holding

Funds holding: 16 → 13 (-3)

55% less capital inflows, than outflows

Capital inflows: $1.65M | Capital outflows: $3.63M

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $361K

Holders
13
Holders Change
-3
Holders Change %
-18.75%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
2
Closed
5
Calls
–
Puts
$361​K
Net Calls
-⁠$361​K
Net Calls Change
+$2.02​M

KALA Hedge Fund Activity: Q1 2023 in Review

13 of the 6,291 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q1 2023, worth a combined $4.81M — down 63% from $12.8M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of KALA and 2 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 3 added.

The largest buyer was Millennium Management, adding an estimated $1.2M. The largest seller was Clear Street, exiting entirely with an estimated $1.88M sold.

  • 13 institutional investors held KALA BIO (KALA) as of Q1 2023, down from 16 in Q4 2022.
  • Funds reported $4.81M of KALA BIO stock for Q1 2023, down 63% quarter-over-quarter.
  • 2 funds opened new KALA BIO positions in Q1 2023 and 5 closed out, a net change of -3 holders.
  • The largest KALA BIO buyer in Q1 2023 was Millennium Management, an estimated $1.2M added.
  • The largest KALA BIO seller in Q1 2023 was Clear Street, an estimated $1.88M sold.

Based on aggregated 13F filings for Q1 2023.